Alleviating pain with delta opioid receptor agonists: evidence from experimental models.
J Neural Transm (Vienna)
; 127(4): 661-672, 2020 04.
Article
em En
| MEDLINE
| ID: mdl-32189076
ABSTRACT
The use of opioids for the relief of pain and headache disorders has been studied for years. Nowadays, particularly because of its ability to produce analgesia in various pain models, delta opioid receptor (DOPr) emerges as a promising target for the development of new pain therapies. Indeed, their potential to avoid the unwanted effects commonly observed with clinically used opioids acting at the mu opioid receptor (MOPr) suggests that DOPr agonists could be a therapeutic option. In this review, we discuss the use of opioids in the management of pain in addition to describing the evidence of the analgesic potency of DOPr agonists in animal models.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Receptores Opioides delta
/
Dor Aguda
/
Dor Crônica
/
Dor do Câncer
/
Analgésicos Opioides
/
Transtornos de Enxaqueca
/
Neuralgia
Limite:
Animals
/
Humans
Idioma:
En
Revista:
J Neural Transm (Vienna)
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Canadá